Showing 1,539 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Gilead, Vertex and the Mystery of Missing Hep C Patients

Editor's pick
The Street
13 February 2012
Access to healthcare

SA announces HIV drugs partnership

Editor's pick
News24
10 February 2012
Access to healthcare

EU drive to protect drug firms puts fight against Aids at risk

Editor's pick
The Independent
10 February 2012
Access to healthcare

Sir Elton John: We must end the greed of these corporations

Editor's pick
The Independent
10 February 2012
Neurological & cognitive problems

NeurogesX Fails to Win U.S. FDA Panel Backing for Patch to Treat HIV Pain

Editor's pick
Bloomberg
9 February 2012
Access to healthcare

Uganda makes new AIDS drug

Editor's pick
Key Correspondents
9 February 2012
Bad science & bogus treatments

Uganda: Three Held Over Defective Drugs

Editor's pick
AllAfrica
9 February 2012
Neurological & cognitive problems

NeurogesX Patch for HIV Pain Might Be Ineffective, FDA Staff Report Says

Editor's pick
Bloomberg
7 February 2012
Pharmaceutical industry

FDA fast-tracks Salix's diarrhea drug review

Editor's pick
Reuters
7 February 2012
Pharmaceutical industry

Merck & Co enjoys healthy quarter but expects flat sales in 2012

Editor's pick
Pharma Times
6 February 2012
New & experimental hepatitis C treatment

Gilead Gains on Positive Data From Experimental Hepatitis C Drug

Editor's pick
Bloomberg
3 February 2012
Types of HIV tests

Chembio, OraSure vie over Over The Counter HIV tests

Editor's pick
Long Island Business News
3 February 2012
Access to healthcare

Key Generic Manufacturer Emcure Joins the Medicines Patent Pool

Editor's pick
Medicines Patent Pool
3 February 2012
Pharmaceutical industry

Gilead Sciences 4Q profit rises on HIV drug sales

Editor's pick
CBS News
2 February 2012
Access to healthcare

Statement on Johnson & Johnson Decision on Negotiations

Editor's pick
Medicines Patent Pool
2 February 2012
Pharmaceutical industry

Gilead tops table for antivirals

Editor's pick
Pharma Times
30 January 2012
Pharmaceutical industry

New products provide solid quarter for B-MS

Editor's pick
Pharma Times
30 January 2012
Access to healthcare

Uganda: Rwanda to Buy Nation's Drugs

Editor's pick
AllAfrica
27 January 2012
Pharmaceutical industry

Top Hepatitis C Virus Biotech Picks By The World's Largest Fund Managers

Editor's pick
Seeking Alpha
25 January 2012
New & experimental hepatitis C treatment

Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race

Editor's pick
Xconomy
25 January 2012
New & experimental HIV treatments

Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir

Editor's pick
Gilead press release
24 January 2012
PrEP

Gilead not immune to concern over Truvada's wider HIV use

Editor's pick
Financial Times
24 January 2012
New & experimental hepatitis C treatment

Achillion's Hep C Pipeline Likely Can't Compete

Editor's pick
BioMed Reports
19 January 2012
HIV treatment for children & young people

U.S. Food and Drug Administration Approves New Formulations of Viread(R) for Use by Children Living With HIV

Editor's pick
CNBC
19 January 2012